Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608296 · ClinicalTrials.gov registry record
Functional and Neurochemical Brain Changes Bipolar Depression
A clinical trial of Depression, Bipolar, sponsored by University of Cincinnati.
- Completed
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT00608296 is a study of Depression, Bipolar that has completed, run by University of Cincinnati. The registered enrollment target is 120 participants, below the 704-participant average among 5 other Depression, Bipolar trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00608296, a study of Depression, Bipolar, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving quetiapine or lithium, in order to better understand who benefits from treatment and why they respond to medications.
Conditions Studied
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00608296
The ClinicalTrials.gov registry entry for NCT00608296 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 704-participant average among 5 other Depression, Bipolar trials with a reported enrollment target (83% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression, Bipolar appearing as the primary indexed condition, and to 0 interventions.
NCT00608296 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00608296 about?
NCT00608296 is a clinical study titled "Functional and Neurochemical Brain Changes Bipolar Depression". The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving quetiapine or lithium, in order to better understand who benefits from treatment and why they respond to medications.
What is the current status of trial NCT00608296?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2008-01. Estimated completion is 2013-07.
What conditions does trial NCT00608296 study?
This clinical trial studies the following conditions: Depression, Bipolar.
Who is sponsoring clinical trial NCT00608296?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00608296 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Bipolar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
RECRUITING · Phase 2
-
Dallas 2K: A Natural History Study of Depression
RECRUITING
-
Depakote ER in Bipolar Depression
COMPLETED · Phase 4
-
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
COMPLETED · Phase 3
-
Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.